Bacterial macromolecules (proteins and nucleic acids)

Bacterial macromolecules, specifically proteins and nucleic acids, are the primary targets of formaldehyde released from the prodrug methenamine (StatPearls, 2023, https://www.ncbi.nlm.nih.gov/books/NBK540994/). In the acidic environment of the urinary tract, methenamine undergoes hydrolysis to generate formaldehyde, which acts as a non-specific, broad-spectrum antimicrobial agent (PubChem, CID 4101, https://pubchem.ncbi.nlm.nih.gov/compound/Methenamine). Formaldehyde exerts its effect by denaturing bacterial proteins and alkylating or cross-linking DNA and RNA, effectively disrupting the structural integrity and metabolic functions of the bacterial cell (FDA, Hiprex Label, https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/017681s013lbl.pdf). This multi-target mechanism of action is highly effective against both Gram-positive and Gram-negative bacteria and significantly reduces the likelihood of developing antimicrobial resistance. Methenamine is clinically utilized for the prevention and long-term management of chronic or recurrent urinary tract infections, provided the urine remains sufficiently acidic to facilitate the conversion to its active form.

Other names

Bacterial proteinsBacterial DNABacterial RNABacterial cell components

Methenamine acts as a prodrug that undergoes chemical hydrolysis in an acidic environment (urine pH 5.5 or less) to generate formaldehyde and ammonia. Formaldehyde is the active moiety that non-specifically denatures bacterial proteins and alkylates or cross-links nucleic acids, resulting in a broad-spectrum bactericidal effect (StatPearls, 2023, https://www.ncbi.nlm.nih.gov/books/NBK540994/; PubChem, CID 4101, https://pubchem.ncbi.nlm.nih.gov/compound/Methenamine).